Lp(a) Lowering: New ASCVD Therapies Emerge
The Lp(a) Revolution: How New Therapies Could Rewrite Cardiovascular Risk For decades, cholesterol has been the primary target in the fight against heart disease. But a growing body of evidence points to another, often overlooked, player: lipoprotein(a), or Lp(a). Genetic predisposition largely dictates Lp(a) levels, and shockingly, even individuals with optimal cholesterol profiles can face … Read more